Core Laboratories NV (CLB):企業の財務・戦略的SWOT分析

◆英語タイトル:Core Laboratories NV (CLB) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1153
◆発行会社(調査会社):GlobalData
◆発行日:2020年3月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:Oil and Gas
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Core Laboratories NV (CLB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Core Laboratories NV (Core Lab) is an oil and gas service provider. It offers patented and proprietary reservoir description and reservoir management services. Core Lab portfolio includes inspection, testing & calibration, core analysis, reservoir fluid analysis, instruments, integrated reservoir solutions and others to major national and independent oil companies. The company also provides laboratory equipment to client company research labs, universities and government institutes. Core Lab’s patented technologies include SpectraChem, SpectraFlood, SMAX, PACKSCAN, SuperHERO, SuperHERO Plus, X-SPAN, ZERO WASH and GTX-SPAN among others. The company has operational presence in countires including the US, Canada and others globally. Core Lab is headquartered in Amsterdam, the Netherlands.

Core Laboratories NV Key Recent Developments

Jan 29,2020: Core Lab Reports Fourth Quarter 2019 Results From Continuing Operations
Dec 30,2019: Core Lab reports Q4 2019 results
Oct 23,2019: Core Lab Reports Third Quarter 2019 Results From Continuing Operations
Jul 24,2019: Core Lab Reports Second Quarter 2019 Results From Continuing Operations:
Apr 24,2019: Core Lab reports first quarter 2019 results from continuing operations

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Core Laboratories NV – Key Facts
Core Laboratories NV – Key Employees
Core Laboratories NV – Key Employee Biographies
Core Laboratories NV – Major Products and Services
Core Laboratories NV – History
Core Laboratories NV – Company Statement
Core Laboratories NV – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Core Laboratories NV – Business Description
Business Segment: Production Enhancement
Overview
Performance
Business Segment: Reservoir Description
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Canada
Performance
Geographical Segment: Europe/Africa/Middle East
Performance
Geographical Segment: Former Soviet Union
Performance
Geographical Segment: Latin/ South America
Performance
Geographical Segment: United States
Performance
Core Laboratories NV – Corporate Strategy
Core Laboratories NV – SWOT Analysis
SWOT Analysis – Overview
Core Laboratories NV – Strengths
Core Laboratories NV – Weaknesses
Core Laboratories NV – Opportunities
Core Laboratories NV – Threats
Core Laboratories NV – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Oil & Gas Financial Deals and Alliances
Core Laboratories NV, Oil & Gas, Deals By Year, 2014 to YTD 2020
Core Laboratories NV, Oil & Gas, Deals By Type, 2014 to YTD 2020
Core Laboratories NV, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 29, 2020: Core Lab Reports Fourth Quarter 2019 Results From Continuing Operations
Dec 30, 2019: Core Lab reports Q4 2019 results
Oct 23, 2019: Core Lab Reports Third Quarter 2019 Results From Continuing Operations
Jul 24, 2019: Core Lab Reports Second Quarter 2019 Results From Continuing Operations:
Apr 24, 2019: Core Lab reports first quarter 2019 results from continuing operations
Jan 30, 2019: Core Lab reports fourth quarter 2018 results from continuing operations
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Core Laboratories NV, Key Facts
Core Laboratories NV, Key Employees
Core Laboratories NV, Key Employee Biographies
Core Laboratories NV, Major Products and Services
Core Laboratories NV, History
Core Laboratories NV, Subsidiaries
Core Laboratories NV, Key Competitors
Core Laboratories NV, Ratios based on current share price
Core Laboratories NV, Annual Ratios
Core Laboratories NV, Annual Ratios (Cont...1)
Core Laboratories NV, Annual Ratios (Cont...2)
Core Laboratories NV, Interim Ratios
Core Laboratories NV, Oil & Gas, Deals By Year, 2014 to YTD 2020
Core Laboratories NV, Oil & Gas, Deals By Type, 2014 to YTD 2020
Core Laboratories NV, Recent Deals Summary
Currency Codes
Units
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Core Laboratories NV, Performance Chart (2015 - 2019)
Core Laboratories NV, Ratio Charts
Core Laboratories NV, Oil & Gas, Deals By Year, 2014 to YTD 2020
Core Laboratories NV, Oil & Gas, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Core Laboratories NV (CLB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MedImmune LLC-製薬・医療分野:企業M&A・提携分析
    Summary MedImmune LLC (MedImmune), a subsidiary of AstraZeneca Plc, is a biotechnology company. It focuses on the research, development, manufacture and marketing of small molecules and biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibo …
  • Eurazeo SA:企業のM&A・事業提携・投資動向
    Eurazeo SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurazeo SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • KLM Catering Services Schiphol bv:企業の戦略・SWOT・財務分析
    KLM Catering Services Schiphol bv - Strategy, SWOT and Corporate Finance Report Summary KLM Catering Services Schiphol bv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Curemark LLC-医療機器分野:企業M&A・提携分析
    Summary Curemark LLC (Curemark) is a biopharmaceutical company that offers development of novel therapies. The company develops novel therapies to treat serious diseases for which there are limited treatment options. It provides CM-AT, CM-4612, CM-PK, CM-182, and CM-1212 drugs. Curemark’s product ca …
  • SEAS-NVE Holding AS:企業の戦略的SWOT分析
    SEAS-NVE Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Crossject SA (ALCJ)-医療機器分野:企業M&A・提携分析
    Summary Crossject SA (Crossject) is a medical device company that develops injection systems. The company offers products which include methotrexate, epinephrin, sumatriptan, L15, naloxone, apomorphine, and midazolam. It uses its needle-free injection system to develop a pipeline of supergenerics by …
  • Bank of Ayudhya Public Co Ltd (BAY):企業の財務・戦略的SWOT分析
    Bank of Ayudhya Public Co Ltd (BAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Smiths Group Plc (SMIN):医療機器:M&Aディール及び事業提携情報
    Summary Smiths Group Plc (Smiths Group) is a diversified technology company. It offers critical solutions for energy and process industries, medical devices and consumables, devices for detection and identification of security threats and contraband, solutions for high speed connectivity and compone …
  • Shin Poong PharmCo Ltd (019170):製薬・医療:M&Aディール及び事業提携情報
    Summary Shin Poong PharmCo Ltd (Shin Poong) is a contract manufacturing company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. The company provides drugs such as psychoneurotic, anti-cancer, cardiovascular, antihistamine, antirheumatic and benign prostat …
  • Vascular Biogenics Ltd (VBLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Vascular Biogenics Ltd (VBL) is a clinical biopharmaceutical company that discovers, develops and commercializes treatments for cancer. The company’s product pipeline includes VB-111. VBL’s product VB-111 is an anti-angiogenic agent for the specific inhibition of tumor vascular growth for ca …
  • Saudi Chemical Company (2230):企業の財務・戦略的SWOT分析
    Saudi Chemical Company (2230) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Oncolytics Biotech Inc (ONC)-医療機器分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • Sinclair Pharma Plc (SPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is an aesthetics company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatological products for facial aesthetics, particularly for facial rejuvenation, through collag …
  • Energias de Portugal S.A:企業の戦略・SWOT・財務分析
    Energias de Portugal S.A - Strategy, SWOT and Corporate Finance Report Summary Energias de Portugal S.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Plexus Corp (PLXS):企業の財務・戦略的SWOT分析
    Plexus Corp (PLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Falco SD Holdings Co Ltd (4671):企業の財務・戦略的SWOT分析
    Summary Falco SD Holdings Co Ltd (Falco), formerly Falco Biosystems Ltd is a clinical testing and dispensing pharmacy service provider. The company offers services such as genetic testing, clinical trials, medical information systems development, and food sanitation and environmental testing. It pro …
  • M. A. Mortenson Co:戦略・SWOT・企業財務分析
    M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report Summary M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • AdvanDx Inc-医療機器分野:企業M&A・提携分析
    Summary AdvanDx Inc (AdvanDx), a subsidiary of OpGen Inc is a healthcare solution provider that offers rapid and accurate molecular diagnostic tests for identification of pathogens causing critical infections in hospitalized patients. The company operates molecular testing of positive blood cultures …
  • Sime Darby Berhad:企業の戦略・SWOT・財務分析
    Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • First Takaful Insurance Company:企業の戦略・SWOT・財務情報
    First Takaful Insurance Company - Strategy, SWOT and Corporate Finance Report Summary First Takaful Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆